Treatment

IAG933 clinical trials

1 indexed studies · 0 currently recruiting

Active not recruitingPHASE1
A Phase I Study of IAG933 in Patients With Advanced Mesothelioma and Other Solid Tumors
This study is testing a new drug, IAG933, for people with advanced mesothelioma and certain other cancers. It aims to find a safe dose and see how well it works when standard treatments haven't helped or aren't suitable.
For: Mesothelioma
United States · Australia · Canada